Hotspur makes dialysis treatments less invasive

Hotspur Technologies, a Mountain View, CA-based company, received FDA clearance for three products based on its blood-vessel-opening technology. Instead of requiring multiple catheters treatments, Hotspur's catheters can perform all peripheral vascular and dialysis procedures. The devices will be on the market by the end of the year. Hotspur release

Suggested Articles

The CE Mark for the system’s fourth iteration follows a July 2019 approval from the FDA.

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.